首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   219篇
  免费   11篇
耳鼻咽喉   7篇
儿科学   3篇
妇产科学   1篇
基础医学   15篇
口腔科学   3篇
临床医学   21篇
内科学   60篇
神经病学   22篇
特种医学   13篇
外科学   13篇
综合类   31篇
预防医学   9篇
眼科学   1篇
药学   12篇
中国医学   18篇
肿瘤学   1篇
  2023年   1篇
  2022年   2篇
  2021年   3篇
  2020年   8篇
  2019年   13篇
  2018年   23篇
  2017年   8篇
  2016年   5篇
  2015年   6篇
  2014年   25篇
  2013年   21篇
  2012年   16篇
  2011年   28篇
  2010年   12篇
  2009年   15篇
  2008年   13篇
  2007年   12篇
  2006年   8篇
  2005年   4篇
  2004年   1篇
  2003年   2篇
  2002年   1篇
  1997年   1篇
  1995年   1篇
  1988年   1篇
排序方式: 共有230条查询结果,搜索用时 156 毫秒
101.
林冰  何春水  林瑶  王刚 《四川医学》2014,(11):1415-1418
目的以成都某高校退休教职工为研究对象,分析踝肱指数及臂踝脉搏波传导速度与各影响因素的相关性,研究该人群中患动脉粥样硬化及周围动脉硬化闭塞性疾病的特征性。方法研究对象选自成都某高校退休教职工体检人群,进行ABI值及Ba PWV值的测定,并收集其性别、年龄、体重、身高,吸烟状况以及有无高血压、糖尿病、血脂异常疾病史等信息,进行数据分析。结果研究对象的ABI值范围在0.85~1.68,平均值为(1.11±0.09),ABI值与年龄相关性较弱(r=0.224,P=0.001),与BMI值的相关性无统计学意义(r=-0.083,P=0.238)。ABI值在男女性别、有无吸烟史及有无高血压病史间差异有统计学意义(P<0.05)。Ba PWV值为1045~3791.5,平均值为(1781.23±410.82),与年龄显著相关(r=0.570,P=0.000),与BMI值的相关性无统计学意义(r=-0.079,P=0.262)。结论周围动脉硬化闭塞症与动脉粥样硬化的发生、发展与年龄、吸烟、高血压、糖尿病、血脂异常等危险因素密切相关,早期检测动脉硬化闭塞疾病指标,及早采取干预措施,对保护心脑血管、减少心血管事件的发生有着十分重要的作用。  相似文献   
102.
目的 探讨糖尿病患者踝肱比(ABI)与足坏疽发生的关系.方法 对60例2型糖尿病足坏疽患者进行踝肱比测量,根据测量结果分为正常、轻度异常、中度异常以及重度异常4组并进行分析.结果 正常者30例占50.00%,轻度异常者5例占8.33%,中度异常者4例占6.67%,重度异常者2l例占35.00%.结论 正常的ABI值并不代表2型糖尿病患者的足部无坏疽或坏疽倾向.  相似文献   
103.
This study investigated the suitability of a two step real-time RT-PCR melting curve analysis as a tool for the detection and discrimination of nine species in the plant virus family Luteoviridae, being Soybean dwarf virus [SbDV], Bean leafroll virus [BLRV], Beet chlorosis virus [BChV], Beet mild yellowing virus [BMYV], Beet western yellows virus [BWYV], Cereal yellow dwarf virus-RPV [CYDV-RPV], Cucurbit aphid-borne yellows virus [CABYV], Potato leafroll virus [PLRV] and Turnip yellows virus [TuYV]. Melting temperature and shape of the melting peak were analysed for 68 bp and 148 bp coat protein gene amplicons using SYBR® GreenER™ fluorescent dye. Specific melting peaks with unique melting temperature were observed for the various species of the family Luteoviridae using the 68 bp amplicon, but not with the 148 bp amplicon. Due to the high variability of sequences for some members of this family, different melting temperatures were also observed between different isolates of the species CYDV-RPV and TuYV. Nevertheless, discrimination between species was achieved for SbDV, BLRV, BChV, BMYV, CABYV and either PLRV or BWYV. Melting curve analysis, in this study, is a faster and more discriminatory alternative to gel electrophoresis of end-point PCR products for the detection of Luteoviridae infection.  相似文献   
104.

Purpose

To evaluate 2-year results of the Zilver PTX (Cook Medical, Bloomington, Indiana) drug-eluting stent (DES) for femoropopliteal peripheral artery disease (PAD) in patients with no continuous patent infrapopliteal runoff arteries compared with patients with ≥ 1 continuous patent runoff vessels.

Materials and Methods

A retrospective analysis of patients with femoropopliteal PAD enrolled in the Zilver PTX Post-Market Surveillance Study in Japan was performed. There were no exclusion criteria. Outcomes, including freedom from target lesion revascularization (TLR), patency, and clinical benefit, for the no-runoff group (n = 54) were compared with the runoff group (n = 846).

Results

The 2 groups were similar in terms of demographics, lesion characteristics, and comorbidities (P > .05). There was a higher incidence of critical limb ischemia in the no-runoff group compared with the runoff group (44.8% vs 19.7%; P < .01). There were 3 amputations (5.6%) in the no-runoff group versus 7 amputations (0.8%) in the runoff group (P = .02). At 2 years, freedom from TLR rates were 81.3% versus 83.8% (P = .87), patency rates were 68.4% versus 70.7% (P = .95), and clinical benefit rates were 73.7% versus 80.0% (P = .16) in the no-runoff versus runoff group, respectively.

Conclusions

Results in patients with no continuous patent tibial runoff were favorable through 2 years and similar to results for patients with ≥ 1 continuous patent runoff vessels, indicating that the Zilver PTX DES may be a valid treatment option for patients with these difficult-to-treat lesions.  相似文献   
105.
PurposeTo identify the spectrum of clinical presentation of iliac artery fibromuscular dysplasia (FMD) and to evaluate the outcomes of endovascular management of iliac artery FMD for claudication.Materials and MethodsAll patients in a single institution with a diagnosis of FMD between January 1980 and December 2010 were identified. Iliac artery FMD was present in 14 patients. Associated risk factors included hypertension (79%), hyperlipidemia (64%), smoking history (36%), coronary artery disease (21%), diabetes (0%), and obesity (36%).ResultsIn eight (57%) patients, iliac artery FMD was incidentally found on imaging. Lifestyle-limiting claudication involving one or both extremities was present in six (43%) patients. All six patients were reported to have mild peripheral arterial disease based on ankle-brachial index measurements (0.7–0.9). These six patients underwent 10 endovascular procedures for claudication, including angioplasty (n = 8) and self-expanding stent placement (n = 2). Mean symptom-free survival was 56.3 months.ConclusionsIliac artery FMD that is amenable to endovascular treatment may be found incidentally or may manifest with disabling claudication.  相似文献   
106.
PurposeTo compare the safety and efficacy of ultrasound-accelerated thrombolysis (UAT) and standard catheter-directed thrombolysis (CDT) in patients with acute and subacute limb ischemia.Materials and MethodsMedical records of all patients treated with thrombolysis for acute and subacute limb ischemia between August 2005 and January 2012 were reviewed. Coprimary (increase in ankle-brachial index, degree of lysis) and secondary endpoints (technical success, distal embolization, bleeding complications, need for additional interventions) were assessed. UAT was performed in 75 patients, and CDT was performed in 27 patients. Patients’ baseline demographic and clinical parameters and procedure details, including lytic drug infusion rate (P = .704 and P = .987), total infusion time (P = .787 and P = .377), and use of adjunctive procedures (P = .457), did not differ significantly between the two groups.ResultsComplete lysis was achieved in 72.0% (UAT) and 63.0% (CDT) of patients (P = .542); hemodynamic success was achieved in 91.8% (UAT) and 92.3% (CDT) (P = .956). Overall major and minor bleeding complications were observed in 6.9% (UAT) and 3.9% (CDT) of patients. Major (P = .075) and minor (P = .276) bleeding independently did not differ between UAT and CDT. Major and minor bleeding combined was lower: 6.7% (UAT) versus 22.2% (CDT) (P = .025). Overall target vessel patency after 8.0 months (range, 1.5–20.5 mo) was 73.5%; target vessel patency for UAT was 75.9% versus 64.3% for CDT (P = .379). Median long-term survival was not significantly different between UAT and CDT: 3.6 years (range, 2.42–5.33 y) versus 1.8 years (range, 1.33–4.92 y) (P = .061).ConclusionsBoth UAT and CDT are safe and efficient treatment modalities for patients with acute and subacute limb ischemia. The observed lower risk of total bleeding for UAT versus CDT may warrant prospective comparative trials.  相似文献   
107.
Introduction: Indications for auditory brainstem implants (ABIs) have been widened from patients with neurofibromatosis type 2 (NF2) to paediatric patients with congenital cochlear malformations, cochlear nerve hypoplasia/aplasia, or cochlear ossification after meningitis. We present four ABI surgeries performed in children at Uppsala University Hospital in Sweden since 2009.

Methods: Three children were implanted with implants from Cochlear Ltd. (Lane Cove, Australia) and one child with an implant from MedEl GMBH (Innsbruck, Austria). A boy with Goldenhar syndrome was implanted with a Cochlear Nucleus ABI24M at age 2 years (patient 1). Another boy with CHARGE syndrome was implanted with a Cochlear Nucleus ABI541 at age 2.5 years (patient 2). Another boy with post-ossification meningitis was implanted with a Cochlear Nucleus ABI24M at age 4 years (patient 3). A girl with cochlear aplasia was implanted with a MedEl Synchrony ABI at age 3 years (patient 4). In patients 1, 2, and 3, the trans-labyrinthine approach was used, and in patient 4 the retro-sigmoid approach was used.

Results: Three of the four children benefited from their ABIs and use it full time. Two of the full time users had categories of auditory performance (CAP) score of 4 at their last follow up visit (6 and 2.5 years postoperative) which means they can discriminate consistently any combination of two of Ling's sounds. One child has not been fully evaluated yet, but is a full time user and had CAP 2 (responds to speech sounds) after 3 months of ABI use. No severe side or unpleasant stimulation effects have been observed so far. There was one case of immediate electrode migration and one case of implant device failure after 6.5 years.

Conclusion: ABI should be considered as an option in the rehabilitation of children with similar diagnoses.  相似文献   
108.
目的了解同时罹患多种动脉粥样硬化疾病或危险因素时其肱-腘动脉脉搏波传导速度(baPWV)、胫后动脉与肱动脉收缩压的比值(ABI)与无危险因素组之间的关系,证明baPWV、ABI对动脉粥样硬化强度的早期预测价值。方法入选病例2033例,采集病史、年龄、血压、体重指数(BMI)、血糖(GU)、血浆总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、尿酸(UA)、左右baPWV(LbaPWV、RbaPWV)、左右ABI(LABI、RABI)等指标,根据动脉粥样硬化性疾病或危险因素的多少将病例进行分组。应用SPSS19.0统计软件包对比分析各观察组与对照组之间baPWV、ABI的差异。结果同时具有3个或3个以上、2个、1个动脉粥样硬化危险因素组,其baPWV与无危险因素组比较,均明显增高,P〈0.001,差异有统计学意义;ABI在不同组之间比较,部分差异显著、部分差异不显著,相关性较差。结论 baPWV与动脉粥样硬化危险因素的相关性良好,危险因素越多相关性越强,可作为一项独立预测因子,在早期识别普通人群动脉硬化程度、早期干预和早期诊断动脉血管硬化中具有明确的指导价值。ABI与危险因素的多少相关性较差。  相似文献   
109.
110.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号